Transplant
From the Journals
Cytokine release syndrome in severe COVID-19: Is tocilizumab effective?
Guidelines
COVID-19: ASTCT provides interim guidelines for transplantation
The American Society for Transplantation and Cellular Therapy document focuses on patient-treatment specifics and donor issues.
Conference Coverage
Second transplant a good salvage option for children with ALL, AML, or MDS
From the Journals
NMA haploidentical allo-BMT plus post-transplant cyclophosphamide deemed safe, effective for CLL
Patients with less than 20% marrow CLL involvement before transplant had an improved 4 year survival.
Conference Coverage
Younger children can safely visit HSCT recipients (sometimes)
Children under 12 are welcome – with suitable precautions – to visit patients at some transplant centers, but personae non grata at others.
Conference Coverage
HIV free 30 months after stem cell transplant, is the London patient cured?
Conference Coverage
Stored CD34 cells for multiple myeloma patients largely unused
ORLANDO –
Conference Coverage
No reduction in oral mucositis with folinic acid post transplant
ORLANDO – Folinic acid, a.k.a. leucovorin, offered no benefit for reducing methotrexate-induced oral mucositis in patients receiving GVHD...
From the Journals
Safer CAR uses modified NK cells for advanced CLL, NHL
From the Journals
Survival for older AML patients better with HSCT from unrelated donors
“Our findings lend support to our hypothesis that a young [matched unrelated donor] should be the donor of choice when available,” reported the...
From the Journals
CAR T-cell therapy may worsen mental health in some patients